Detalhe da pesquisa
1.
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Lancet Oncol
; 20(12): 1730-1739, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727538
2.
Clinical effectiveness of docetaxel for castration-sensitive prostate cancer in a real-world population-based analysis.
Prostate
; 79(3): 281-287, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370697
3.
The impact of time to metastasis on overall survival in patients with prostate cancer.
World J Urol
; 36(7): 1039-1046, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29488095
4.
Platinum-based chemotherapy in triple-negative advanced breast cancer.
Breast Cancer Res Treat
; 146(3): 567-72, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25001611
5.
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.
Nat Commun
; 15(1): 1828, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418825
6.
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.
Can Urol Assoc J
; 17(10): 326-336, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494316
7.
Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade.
Front Oncol
; 12: 973402, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36176410
8.
Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer-a narrative review.
Transl Androl Urol
; 10(10): 3931-3945, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34804836
9.
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score-weighted comparative cohort study.
Eur J Cancer
; 152: 215-222, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130153
10.
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.
Clin Cancer Res
; 27(6): 1650-1662, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414135
11.
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.
Clin Cancer Res
; 27(16): 4610-4623, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083234
12.
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.
Can Urol Assoc J
; 15(10): 353-358, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125066
13.
Erratum to: platinum-based chemotherapy in triple-negative advanced breast cancer.
Breast Cancer Res Treat
; 150(3): 697, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809091
14.
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.
Clin Cancer Res
; 26(5): 1114-1125, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31744831
15.
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial.
Eur Urol
; 75(6): 940-947, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591354
16.
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum.
J Clin Oncol
; 37(33): 3090-3098, 2019 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553692
17.
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Eur Urol
; 75(4): 667-675, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30638634
18.
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923850
19.
A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.
Can Urol Assoc J
; 12(2): E47-E52, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29381456
20.
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.
Cancer Discov
; 8(4): 444-457, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29367197